|
1
|
WHO International Agency for Research on
Cancer (IARC): Globocan 2012: Estimated cancer incidence, mortality
and prevalence worldwide in 2012. WHO. Geneva: 2012.
|
|
2
|
Chen B, Zhang B, Xia L, Zhang J, Chen Y,
Hu Q and Zhu C: Knockdown of eukaryotic translation initiation
factor 4E suppresses cell growth and invasion, and induces
apoptosis and cell cycle arrest in a human lung adenocarcinoma cell
line. Mol Med Rep. 12:7971–7978. 2015.PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun Y, Ai X, Shen S and Lu S:
NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung
cancer by targeting MYO10. Oncotarget. 2:1–11. 2015.
|
|
5
|
Lander ES, Linton LM, Birren B, Nusbaum C,
Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al:
International Human Genome Sequencing Consortium: Initial
sequencing and analysis of the human genome. Nature. 409:860–921.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ohno S: So much ‘junk’ DNA in our genome.
Brookhaven Symp Biol. 23:366–370. 1972.PubMed/NCBI
|
|
7
|
Peters L and Meister G: Argonaute
proteins: Mediators of RNA silencing. Mol Cell. 26:611–623. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hutvagner G and Simard MJ: Argonaute
proteins: Key players in RNA silencing. Nat Rev Mol Cell Biol.
9:22–32. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Siomi MC, Sato K, Pezic D and Aravin AA:
PIWI-interacting small RNAs: The vanguard of genome defence. Nat
Rev Mol Cell Biol. 12:246–258. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang B, Pan X, Cobb GP and Anderson TA:
MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dieckmann KP, Spiekermann M, Balks T, Flor
I, Löning T, Bullerdiek J and Belge G: MicroRNAs miR-371-3 in serum
as diagnostic tools in the management of testicular germ cell
tumours. Br J Cancer. 107:1754–1760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takahashi M, Cuatrecasas M, Balaguer F,
Hur K, Toiyama Y, Castells A, Boland CR and Goel A: The clinical
significance of MiR-148a as a predictive biomarker in patients with
advanced colorectal cancer. PLoS One. 7:e466842012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aravin A, Gaidatzis D, Pfeffer S,
Lagos-Quintana M, Landgraf P, Iovino N, Morris P, Brownstein MJ,
Kuramochi-Miyagawa S, Nakano T, et al: A novel class of small RNAs
bind to MILI protein in mouse testes. Nature. 442:203–207.
2006.PubMed/NCBI
|
|
14
|
Girard A, Sachidanandam R, Hannon GJ and
Carmell MA: A germline-specific class of small RNAs binds mammalian
Piwi proteins. Nature. 442:199–202. 2006.PubMed/NCBI
|
|
15
|
Grivna ST, Beyret E, Wang Z and Lin H: A
novel class of small RNAs in mouse spermatogenic cells. Genes Dev.
20:1709–1714. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu Y, Li C, Zhang K, Sun H, Tao D, Liu Y,
Zhang S and Ma Y: Identification of piRNAs in Hela cells by massive
parallel sequencing. BMB Rep. 43:635–641. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng J, Deng H, Xiao B, Zhou H, Zhou F,
Shen Z and Guo J: piR-823, a novel non-coding small RNA,
demonstrates in vitro and in vivo tumor suppressive activity in
human gastric cancer cells. Cancer Lett. 315:12–17. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng J, Guo JM, Xiao BX, Miao Y, Jiang Z,
Zhou H and Li QN: piRNA, the new non-coding RNA, is aberrantly
expressed in human cancer cells. Clin Chim Acta. 412:1621–1625.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang H, Ren Y, Xu H, Pang D, Duan C and
Liu C: The expression of stem cell protein Piwil2 and piR-932 in
breast cancer. Surg Oncol. 22:217–223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang G, Hu H, Xue X, Shen S, Gao E, Guo
G, Shen X and Zhang X: Altered expression of piRNAs and their
relation with clinicopathologic features of breast cancer. Clin
Transl Oncol. 15:563–568. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chu H, Hui G, Yuan L, Shi D, Wang Y, Du M,
Zhong D, Ma L, Tong N, Qin C, et al: Identification of novel piRNAs
in bladder cancer. Cancer Lett. 356(2 Pt B): 561–567. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Law PT, Qin H, Ching AK, Lai KP, Co NN, He
M, Lung RW, Chan AW, Chan TF and Wong N: Deep sequencing of small
RNA transcriptome reveals novel non-coding RNAs in hepatocellular
carcinoma. J Hepatol. 58:1165–1173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X, Yan S, Pei C and Cui Y: Decreased
microRNA-132 and its function in human non-small cell lung cancer.
Mol Med Rep. 11:3601–3608. 2015.PubMed/NCBI
|
|
24
|
Grimson A, Srivastava M, Fahey B,
Woodcroft BJ, Chiang HR, King N, Degnan BM, Rokhsar DS and Bartel
DP: Early origins and evolution of microRNAs and Piwi-interacting
RNAs in animals. Nature. 455:1193–1197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meister G: Argonaute proteins: Functional
insights and emerging roles. Nat Rev Genet. 14:447–459. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Siddiqi S and Matushansky I: Piwis and
piwi-interacting RNAs in the epigenetics of cancer. J Cell Biochem.
113:373–380. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cryns V and Yuan J: Proteases to die for.
Genes Dev. 12:1551–1570. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang F, Huang M, Zhang H, Zhang C, Zhang
D and Zhou G: Changes in apoptotic factors and caspase activation
pathways during the postmortem aging of beef muscle. Food Chem.
190:110–114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Y, Mayo MW, Xiao A, Hall EH, Amin EB,
Kadota K, Adusumilli PS and Jones DR: Loss of BRMS1 promotes a
mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
Mol Cell Biol. 35:303–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
